|1.||Vessières, Anne: 8 articles (12/2015 - 12/2005)|
|2.||Jaouen, Gérard: 7 articles (12/2015 - 12/2005)|
|3.||Top, Siden: 4 articles (12/2015 - 11/2013)|
|4.||Amatore, Christian: 3 articles (06/2014 - 12/2005)|
|5.||Heldt, Jan Martin: 2 articles (05/2010 - 01/2008)|
|6.||Kiss, Robert: 1 article (12/2014)|
|7.||Mathieu, Véronique: 1 article (12/2014)|
|8.||Pigeon, Pascal: 1 article (12/2014)|
|9.||Bruyère, Céline: 1 article (12/2014)|
|10.||Guille-Collignon, Manon: 1 article (06/2014)|
|1.||Breast Neoplasms (Breast Cancer)
11/21/2013 - "Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species."
06/01/2014 - "Ferrocifens are an original class of ferrocifen-type breast cancer drugs. "
01/01/2008 - "Hydroxyferrocifen compounds are a new and promising class of ferrocifen-type breast-cancer drug candidates. "
06/01/2014 - "In this work, fluorescence measurements indicated the production of reactive oxygen species (ROS) if hormone-dependent or -independent breast cancer cells were incubated with three hit ferrocifen compounds. "
12/23/2005 - "Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates."
12/21/2015 - "Ferrocifen type anti cancer drugs."
12/01/2014 - "Ferrocifen derivatives that induce senescence in cancer cells: selected examples."
01/14/2014 - "We have recently shown that the combination of chemical motifs of vorinostat () and ferrocifen () in the single hybrid produced beneficial effects in terms of antiproliferative activity of both agents against cancer cells. "
05/01/2010 - "The aim of this work was to investigate the mechanism of action of ferrocifen (Fc-OH-TAM), the ferrocenyl analog of 4-hydroxy-tamoxifen (OH-TAM), which is the active metabolite of tamoxifen, the drug most widely prescribed for treatment of hormone-dependent breast cancers. "
|3.||Melanoma (Melanoma, Malignant)
|3.||Reactive Oxygen Species (Oxygen Radicals)
|7.||vorinostat (suberoylanilide hydroxamic acid)